Barclays PLC Xtant Medical Holdings, Inc. Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.38 - $2.46 $4,072 - $7,259	-2,951 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.23 - $4.33 $3,629 - $12,777	2,951 New	2,951 $7,000
Q3 2020 Nov 12, 2020	SELL	$0.76 - $1.6 $15 - $32	-20 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$0.62 - $1.74 $12 - $34	20 New	20 $0
Q4 2018 Feb 14, 2019	SELL	$1.61 - $4.0 $3 - $8	-2 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.85 - $6.2 $1,493 - $2,405	-388 Reduced 99.49%	2 $0
Q2 2018 Aug 14, 2018	BUY	$5.33 - $8.31 $2,078 - $3,240	390 New	390 $2,000

98.2M

Ticker XTNT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 108,226,000
Market Cap $43.3M
Description
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.